Roivant Sciences Ltd Sustainability Reports
Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company focused on accelerating the development and commercialization of medicines. The company builds subsidiary biotech and healthcare technology companies, internally referred to as Vants.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300DL466NY5J6U724
FIGI: BBG007STW2C7
2 reports from 2022 to 2024